Precision BioSciences (NASDAQ:DTIL) just reported results for the first quarter of 2024.
- Precision BioSciences reported earnings per share of -35 cents. This was above the analyst estimate for EPS of -$1.91.
- The company reported revenue of $17.58 million.
- This was 192.09% better than the analyst estimate for revenue of $6.02 million.